What is the efficacy of posttransplant resection to treat recurrent hepatocellular carcinoma (HCC)?

Updated: Jan 31, 2021
  • Author: Luca Cicalese, MD, FACS; Chief Editor: John Geibel, MD, MSc, DSc, AGAF  more...
  • Print

Resection in the posttransplant population can be accomplished in up to one third of patients. In those patients who undergo successful resection, 4-year survival rates increase from 14% to 57%, justifying an aggressive approach. [103]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!